Actinogen Medical Limited (ACW, formerly Actinogen Limited) is an ASX-listed biotechnology company developing innovative treatments for Alzheimer’s disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes. It focusses on the development of Xanamem, a novel treatment for Alzheimer’s disease and the cognitive deficiency associated with other neurological and metabolic diseases within Australia.
Actinogen Medical Limited belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website: http://www.actinogen.com.au.
This a small cap company with market cap of 40 millions.
Compared to Market and Sector
The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.
Company PE is less than both sector and market. while On the other hand, Company Earning is less than both sector and market.
Dividend Growth Chart
The following chart shows you how acw dividend grows in the recent years.